Results 71 to 80 of about 5,634,776 (298)
Role of Transverse Cerebellar Diameter in Diagnosis of Asymmetrical Fetal Growth Restriction
Background: To evaluate the accuracy of transcerebellar diameter and transcerebellar diameter /abdominal circumference ratio (TCD/AC) as independent predictor for asymmetrical fetal growth restriction Methods: In this observational study 30 high risk ...
Nasir Khan
doaj
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla +9 more
wiley +1 more source
Fetal growth restriction (FGR) and pre-eclampsia with fetal growth restriction (PE/FGR) are high-risk perinatal diseases that may involve high levels of human chorionic gonadotropin (hCG) and mitochondrial dysfunction.
Ryo Kiyokoba +7 more
doaj +1 more source
Maternal characteristics predisposing to fetal growth restriction
Fetal growth restriction affects up to 10% of live-born infants representing a major cause of neonatal morbidity and mortality worldwide, being a significant risk factor for future adult health. A reduction of nutrient supply and oxygenation is the final
Francesca Parisi +2 more
core +1 more source
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska +13 more
wiley +1 more source
Sonographic Placental Aspects in Fetal Growth Restriction [PDF]
Fetal growth restriction (FGR) is a complication diagnosed in about 10% of pregnancies and is associated with significant perinatal mortality and morbidity.
Nastasia SERBAN +2 more
core +2 more sources
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura +19 more
wiley +1 more source
Intrauterine growth restriction is an important perinatal problem giving rise to increased morbidity and mortality in the growth restricted fetus. Today the aim is to prevent the occurence of intrauterine growth restriction in high risk pregnancies and ...
Senem Arda Duz
doaj +1 more source
Fetal cardiac remodeling and dysfunction is associated with both preeclampsia and fetal growth restriction [PDF]
Background: Preeclampsia and fetal growth restriction share some pathophysiologic features and are both associated with placental insufficiency. Fetal cardiac remodeling has been described extensively in fetal growth restriction, whereas little is known ...
Sepulveda-Martinez, Alvaro +35 more
core +1 more source
Fetal cerebral Doppler changes and outcome in late preterm fetal growth restriction: prospective cohort study [PDF]
Objectives: To explore the association between fetal umbilical and middle cerebral artery (MCA) Doppler abnormalities and outcome in late preterm pregnancies at risk of fetal growth restriction.
Graupner, O. +230 more
core +3 more sources

